BioNexus Gene Lab Corp. (BGLC)
OTCMKTS: BGLC · Delayed Price · USD
0.514
0.00 (0.02%)
Jul 22, 2024, 9:37 AM EDT - Market open

BioNexus Gene Lab Statistics

Total Valuation

BGLC has a market cap or net worth of $9.08 million. The enterprise value is $27,405.

Market Cap 9.08M
Enterprise Value 27,405

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BGLC has 17.67 million shares outstanding. The number of shares has increased by 22.04% in one year.

Shares Outstanding 17.67M
Shares Change (YoY) +22.04%
Shares Change (QoQ) n/a
Owned by Insiders (%) 64.38%
Owned by Institutions (%) 0.57%
Float 9.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.93
Forward PS n/a
PB Ratio 0.97
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.01.

Current Ratio 4.61
Quick Ratio 5.86
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -151.90

Financial Efficiency

Return on equity (ROE) is -28.51% and return on invested capital (ROIC) is -29.83%.

Return on Equity (ROE) -28.51%
Return on Assets (ROA) -23.87%
Return on Capital (ROIC) -29.83%
Revenue Per Employee $325,848
Profits Per Employee -$88,791
Employee Count 30
Asset Turnover 0.96
Inventory Turnover 8.57

Taxes

In the past 12 months, BGLC has paid $25,604 in taxes.

Income Tax 25,604
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.27% in the last 52 weeks. The beta is 1.85, so BGLC's price volatility has been higher than the market average.

Beta (5Y) 1.85
52-Week Price Change -95.27%
50-Day Moving Average 0.51
200-Day Moving Average 0.59
Relative Strength Index (RSI) 54.77
Average Volume (20 Days) 60,903

Short Selling Information

The latest short interest is 188,900, so 1.07% of the outstanding shares have been sold short.

Short Interest 188,900
Short Previous Month 177,879
Short % of Shares Out 1.07%
Short % of Float 1.90%
Short Ratio (days to cover) 0.65

Income Statement

In the last 12 months, BGLC had revenue of $9.78 million and -$2.66 million in losses. Loss per share was -$0.17.

Revenue 9.78M
Gross Profit 1.31M
Operating Income -2.82M
Pretax Income -2.64M
Net Income -2.66M
EBITDA -2.71M
EBIT -2.82M
Loss Per Share -$0.17
Full Income Statement

Balance Sheet

The company has $5.83 million in cash and $121,354 in debt, giving a net cash position of $9.05 million or $0.51 per share.

Cash & Cash Equivalents 5.83M
Total Debt 121,354
Net Cash 9.05M
Net Cash Per Share $0.51
Equity (Book Value) 9.34M
Book Value Per Share 0.53
Working Capital 6.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.21 million and capital expenditures -$171,241, giving a free cash flow of -$1.38 million.

Operating Cash Flow -1.21M
Capital Expenditures -171,241
Free Cash Flow -1.38M
FCF Per Share -$0.08
Full Cash Flow Statement

Margins

Gross margin is 13.35%, with operating and profit margins of -28.89% and -27.25%.

Gross Margin 13.35%
Operating Margin -28.89%
Pretax Margin -26.99%
Profit Margin -27.25%
EBITDA Margin -27.73%
EBIT Margin -28.89%
FCF Margin -14.15%

Dividends & Yields

BGLC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.04%
Shareholder Yield -22.04%
Earnings Yield -29.33%
FCF Yield -15.23%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on July 20, 2023. It was a reverse split with a ratio of 1:12.

Last Split Date Jul 20, 2023
Split Type Reverse
Split Ratio 1:12

Scores

BGLC has an Altman Z-Score of 3.46 and a Piotroski F-Score of 3.

Altman Z-Score 3.46
Piotroski F-Score 3